MARKET

VRTX

VRTX

Vertex Pharmaceuticals Inc
NASDAQ
466.10
-3.24
-0.69%
After Hours: 461.29 -4.81 -1.03% 19:12 03/16 EDT
OPEN
475.14
PREV CLOSE
469.34
HIGH
476.17
LOW
461.13
VOLUME
1.50M
TURNOVER
--
52 WEEK HIGH
517.20
52 WEEK LOW
362.50
MARKET CAP
118.41B
P/E (TTM)
30.42
1D
5D
1M
3M
1Y
5Y
1D
Analysts Are Bullish on These Healthcare Stocks: Beam Therapeutics (BEAM), Pelthos Therapeutics (PTHS)
TipRanks · 16h ago
Beyond Tech Industry: Here's how Biotech ETFs Are Riding the AI Wave
NASDAQ · 16h ago
Insmed assumed with a Buy at Jefferies
TipRanks · 16h ago
Weekly Report: what happened at VRTX last week (0309-0313)?
Weekly Report · 20h ago
PGIM Jennison Health Sciences Fund Q4 2025 Key Contributors And Detractors
Seeking Alpha · 1d ago
Is Vertex Pharmaceuticals Heading to $600?
The Motley Fool · 1d ago
Notable healthcare headlines for the week: Eli Lilly, Novo Nordisk, and CVS Health in focus
Seeking Alpha · 1d ago
Vertex EVP and Chief Commercial Officer Duncan McKechnie Disposes of Vertex Pharmaceuticals Common Shares
Reuters · 3d ago
More
About VRTX
Vertex Pharmaceuticals Incorporated is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases, with a focus on specialty markets. It has seven approved medicines: five that treat the underlying cause of cystic fibrosis (CF), one that treats severe sickle cell disease (SCD) and transfusion dependent beta thalassemia (TDT), and one that treats moderate-to-severe acute pain. Its pipeline includes clinical-stage programs in CF, SCD, beta thalassemia, acute and peripheral neuropathic pain, APOL1-mediated kidney disease, IgA nephropathy and other autoimmune renal diseases and cytopenias, type 1 diabetes, myotonic dystrophy type 1, and autosomal dominant polycystic kidney disease. Its marketed medicines are TRIKAFTA/KAFTRIO (elexacaftor/tezacaftor/ivacaftor and ivacaftor), SYMDEKO/SYMKEVI (elexacaftor/tezacaftor/ivacaftor and ivacaftor), ORKAMBI (lumacaftor/ivacaftor), and KALYDECO (ivacaftor).

Webull offers Vertex Pharmaceuticals Inc stock information, including NASDAQ: VRTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VRTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VRTX stock methods without spending real money on the virtual paper trading platform.